Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial

Rotsaert A, Essack Z, Bosman S, Davey DJ, Hensen B. Oral pre-exposure prophylaxis initiation, continuation and adherence among pregnant and postpartum women receiving antenatal and[...]

Redekop E, Wang Z, Kulkarni R, Pleasure M, Chin A, Hassanzadeh HR, Hill BL, Emami M, Speier WF, Arnold CW. Zero-shot medical event prediction using[...]

Pollack CE, Blackford AL, Craig TK, Fan Q, Hussaini SMQ, Chen KL, Polsky D, Katana Ogongo M, Warren JL, Gross CP, Yabroff KR. Federal Housing[...]